Btg Share Discussion Threads

[bargainbob] 06/11/2017 09:42

Is a treatment , one leg at a time . Could make a big difference on how you read the update.

4 legs can you help lol.

[bargainbob] 06/11/2017 09:11

It almost like Louise wants the price to be under a certain level .
Shocking update on the codes , we will just need to wait till 2018 to see the impact .
I suggest getting rid of her to save the time.

[ashehzi] 06/11/2017 08:44

good to see it recovering back

[weatherman] 06/11/2017 08:14

At least this should accelerate growth in Varithena - $3000 against a brick wall is not smart.

[cockneytrader] 06/11/2017 07:48

May I remind folk that btg charge $3000 for one can of varithena, yet insurers will only offers $1700 for multiple vein procedure. Shortfall of $1300!

[ashehzi] 06/11/2017 07:36

seems like a buying opportunity for some at discounted price then.

[bill hunt] 06/11/2017 07:17

The good, the bad and the ugly news. Via news. Charges agreed but uncertainty till end of 2018 of impact. Loss of court case and hit of 55 million this half.

[cockneytrader] 06/11/2017 07:15

Shocking!

Two awful pieces of news on the same day. Both Products to be written off?

Down 10 or maybe 20% on this news.

[dp1umb] 05/11/2017 12:34

I can’t see it going much more than £8 but what to I know?

[bargainbob] 05/11/2017 09:23

Good news indeed dp1umb , maybe a period of golden news nuggets about to be released.
Hopefully they can reach a out of court settlement on the recent dispute and move onwards.

[dp1umb] 05/11/2017 08:59

Bob Zytiga has returned to growth with a 25% increase in sales in the last quarter.

[dp1umb] 04/11/2017 12:44

Bargain the problem is it’s patent has expired this quarter will be your last revenue unfortunately unless I’ve missed something? I know the zytiga patent is hard to work out but lemtrada was more straight forward. There should also be news soon regarding the lung device which could be earnings enhancing.

[bargainbob] 04/11/2017 05:42

Think maybe wrong Dave on eye eye eye posted this .

I have taken this dater from todays update from Sanofi 3rd quarter sales, and Lemtrada is doing very nicely it's up 5.4% in just this quarter alone .
BE HAPPY
DAVE , Multiple Sclerosis franchise

Net sales (€ million) Q3 2017 Change
(CER) 9M 2017 Change
(CER)
Aubagio® 382 +19.2% 1,178 +26.9%---------------------------------------------------------------------
Lemtrada® 113 +5.4% 362 +18.5%;--------------------------------------------------------------------
Total Multiple Sclerosis 495 +15.7% 1,540 +24.8%.------------------------------------------------

Third-quarter Multiple Sclerosis (MS) sales grew 15.7% to €495 million, driven by Aubagio® performance in the U.S. and Europe. Year-to-date MS sales increased 24.8% to €1,540 million.

Third-quarter Aubagio® sales increased 19.2% to €382 million driven by the U.S. (up 20.9% to €274 million). In Europe sales of Aubagio were up 16.0% to €86 million. Year-to-date Aubagio® sales increased 26.9% to €1,178 million.

In the third quarter Lemtrada® sales were up 5.4% to €113 million, including €60 million in the U.S. (stable) and €40 million in Europe (up 10.8%). Year-to-date Lemtrada® sales increased 18.5% to €362 million.

[dp1umb] 03/11/2017 17:24

Bargain your right it’s the codes

[bargainbob] 03/11/2017 16:07

Bill hunt , the market forgot the liable bill imho , unless someone is stake building , I suspect the price to follow previous years.

The issuing of the codes finally could bring support though. Suspect news of this before the 14th.

[bill hunt] 03/11/2017 15:42

In recent times the price has spiked before the reporting then retraced significantly after. Hope this is not the case this time around.

[dr biotech] 03/11/2017 15:26

Another decent day today, let’s hope they don’t disappoint. This has been one of my better bio investments

[3rd eye] 02/11/2017 08:51

BTG...pushing on up to Interims on the 14th Nov. EPS seen increasing 84% and P/E of 25 to 2018, (Hist Low)Numis have a 900p share price Target 😎😃

[fhmktg] 01/11/2017 08:46

Good progress over the last six weeks- final code values are 'expected' in November for Varithena.If there are no further downsides in the announcements mid month, we could be set for a significant push in growth for 2018.I hope it doesn't end in tears!

[dp1umb] 27/10/2017 16:02

A very good recovery today

[dp1umb] 24/10/2017 19:43

a1ord how quick sentiment changes last month this board was all doom and gloom with a lot of longterm holders selling up!i myself being in as low as 75p thought about offloading 50%. Fast forward to Friday and hitting 3 year highs. Do you think there's any chance of that happening over at poor old Vectura ? It's got to turn soon,

[a1ord53] 24/10/2017 17:54

bb 100k shares of BTG going to 17£ or 1mil. going to 8,5 £.
HOPEFULLY 17£ ! :)

[bargainbob] 21/10/2017 11:54

Stupid article , how many shares are required etc etc .